{"date":"2026-03-26","count":30,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6748-2026-03-26-1946-1ctgfb2","company_id":"6748","company":"亞果生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-26","time":"19:46:48","subject":"公告本公司董事會通過擬辦理現金增資供初次上市(櫃)或臺灣創新板有價證券之上市前公開承銷暨原股東全數放棄認購案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：亞果生醫（6748），2026-03-26 19:46，「公告本公司董事會通過擬辦理現金增資供初次上市(櫃)或臺灣創新板有價證券之上市前公開承銷暨原股東全數放棄認購案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6748-2026-03-26-1941-1tmyr0r","company_id":"6748","company":"亞果生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-26","time":"19:41:49","subject":"公告本公司擬申請股票上市(櫃)或申請臺灣創新板有價證券之上市案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：亞果生醫（6748），2026-03-26 19:41，「公告本公司擬申請股票上市(櫃)或申請臺灣創新板有價證券之上市案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6748-2026-03-26-1851-13hg1o","company_id":"6748","company":"亞果生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-26","time":"18:51:03","subject":"本公司董事會通過召開115年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：亞果生醫（6748），2026-03-26 18:51，「本公司董事會通過召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6999-2026-03-26-1814-dtyg8o","company_id":"6999","company":"瀚醫生技","market":"興櫃","industry":"生技醫療","date":"2026-03-26","time":"18:14:45","subject":"(更正)公告本公司董事會決議股利分派","clause":"第44款","fact_date":"2026-03-24","cite_as":"公開資訊觀測站重大訊息：瀚醫生技（6999），2026-03-26 18:14，「(更正)公告本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6586-2026-03-26-1813-5rh607","company_id":"6586","company":"醣基","market":"興櫃","industry":"生技醫療","date":"2026-03-26","time":"18:13:01","subject":"公告本公司董事會決議解除經理人競業禁止之限制","clause":"第22款","fact_date":"2026-03-26","cite_as":"公開資訊觀測站重大訊息：醣基（6586），2026-03-26 18:13，「公告本公司董事會決議解除經理人競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6586-2026-03-26-1812-p67uuk","company_id":"6586","company":"醣基","market":"興櫃","industry":"生技醫療","date":"2026-03-26","time":"18:12:40","subject":"公告本公司內部稽核主管異動","clause":"第11款","fact_date":"2026-03-26","cite_as":"公開資訊觀測站重大訊息：醣基（6586），2026-03-26 18:12，「公告本公司內部稽核主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6586-2026-03-26-1811-fk2wyx","company_id":"6586","company":"醣基","market":"興櫃","industry":"生技醫療","date":"2026-03-26","time":"18:11:56","subject":"公告本公司董事會通過財務主管及會計主管任命案","clause":"第11款","fact_date":"2026-03-26","cite_as":"公開資訊觀測站重大訊息：醣基（6586），2026-03-26 18:11，「公告本公司董事會通過財務主管及會計主管任命案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6586-2026-03-26-1811-1howjn","company_id":"6586","company":"醣基","market":"興櫃","industry":"生技醫療","date":"2026-03-26","time":"18:11:30","subject":"公告本公司董事會決議召開115年股東常會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：醣基（6586），2026-03-26 18:11，「公告本公司董事會決議召開115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7725-2026-03-26-1809-d8h6pu","company_id":"7725","company":"列特博","market":"興櫃","industry":"生技醫療","date":"2026-03-26","time":"18:09:50","subject":"公告本公司一年內累積取得同一有價證券達實收資本額百分之二十","clause":"第17款","fact_date":"2026-03-26","cite_as":"公開資訊觀測站重大訊息：列特博（7725），2026-03-26 18:09，「公告本公司一年內累積取得同一有價證券達實收資本額百分之二十」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4735-2026-03-26-1753-1cqq2hy","company_id":"4735","company":"豪展","market":"上櫃","industry":"生技醫療","date":"2026-03-26","time":"17:53:00","subject":"公告本公司一年內累積處分同一有價證券達本公司實收資本額20%以上","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：豪展（4735），2026-03-26 17:53，「公告本公司一年內累積處分同一有價證券達本公司實收資本額20%以上」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4743-2026-03-26-1703-8w05m0","company_id":"4743","company":"合一","market":"上櫃","industry":"生技醫療","date":"2026-03-26","time":"17:03:13","subject":"公告本公司董事會決議擬申請股票轉上市","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合一（4743），2026-03-26 17:03，「公告本公司董事會決議擬申請股票轉上市」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4117-2026-03-26-1636-139v6is","company_id":"4117","company":"普生","market":"興櫃","industry":"生技醫療","date":"2026-03-26","time":"16:36:00","subject":"代子公司GB Holdings Limited及代重要子公司居禮股份有限公司公告換股投資案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：普生（4117），2026-03-26 16:36，「代子公司GB Holdings Limited及代重要子公司居禮股份有限公司公告換股投資案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6815-2026-03-26-1632-11b1948","company_id":"6815","company":"晶鑽生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-26","time":"16:32:08","subject":"公告本公司董事會決議召開115年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：晶鑽生醫（6815），2026-03-26 16:32，「公告本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2026-03-26-1615-d4jsal","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2026-03-26","time":"16:15:51","subject":"公告本公司115年第一次現金增資收足股款暨增資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2026-03-26 16:15，「公告本公司115年第一次現金增資收足股款暨增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6572-2026-03-26-1613-4glz2i","company_id":"6572","company":"博錸","market":"興櫃","industry":"生技醫療","date":"2026-03-26","time":"16:13:44","subject":"本公司董事會決議114年度股利分派","clause":"第31款","fact_date":"2026-03-26","cite_as":"公開資訊觀測站重大訊息：博錸（6572），2026-03-26 16:13，「本公司董事會決議114年度股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4117-2026-03-26-1612-130guww","company_id":"4117","company":"普生","market":"興櫃","industry":"生技醫療","date":"2026-03-26","time":"16:12:31","subject":"代重要子公司居禮股份有限公司公告董事會通過董事長暨總經理續任事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：普生（4117），2026-03-26 16:12，「代重要子公司居禮股份有限公司公告董事會通過董事長暨總經理續任事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4117-2026-03-26-1611-auzqnb","company_id":"4117","company":"普生","market":"興櫃","industry":"生技醫療","date":"2026-03-26","time":"16:11:53","subject":"代重要子公司居禮股份有限公司公告法人董事及監察人指派代表人","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：普生（4117），2026-03-26 16:11，「代重要子公司居禮股份有限公司公告法人董事及監察人指派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6572-2026-03-26-1555-12of6u4","company_id":"6572","company":"博錸","market":"興櫃","industry":"生技醫療","date":"2026-03-26","time":"15:55:00","subject":"公告本公司114年度累積虧損達實收資本額二分之一","clause":"第44款","fact_date":"2026-03-26","cite_as":"公開資訊觀測站重大訊息：博錸（6572），2026-03-26 15:55，「公告本公司114年度累積虧損達實收資本額二分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6572-2026-03-26-1551-1vy0af5","company_id":"6572","company":"博錸","market":"興櫃","industry":"生技醫療","date":"2026-03-26","time":"15:51:32","subject":"本公司董事會通過114年度財務報表","clause":"第43款","fact_date":"2026-03-26","cite_as":"公開資訊觀測站重大訊息：博錸（6572），2026-03-26 15:51，「本公司董事會通過114年度財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6572-2026-03-26-1548-fqsc9p","company_id":"6572","company":"博錸","market":"興櫃","industry":"生技醫療","date":"2026-03-26","time":"15:48:37","subject":"本公司董事會決議召開115年股東常會","clause":"第32款","fact_date":"2026-03-26","cite_as":"公開資訊觀測站重大訊息：博錸（6572），2026-03-26 15:48，「本公司董事會決議召開115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6539-2026-03-26-1522-zo4bo6","company_id":"6539","company":"麗彤","market":"興櫃","industry":"生技醫療","date":"2026-03-26","time":"15:22:08","subject":"114年下半年度盈餘股利配發基準日","clause":"第31款","fact_date":"2026-03-26","cite_as":"公開資訊觀測站重大訊息：麗彤（6539），2026-03-26 15:22，「114年下半年度盈餘股利配發基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6539-2026-03-26-1518-37x834","company_id":"6539","company":"麗彤","market":"興櫃","industry":"生技醫療","date":"2026-03-26","time":"15:18:58","subject":"114年下半年度盈餘分派案","clause":"第31款","fact_date":"2026-03-26","cite_as":"公開資訊觀測站重大訊息：麗彤（6539），2026-03-26 15:18，「114年下半年度盈餘分派案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6748-2026-03-26-1517-rpor3r","company_id":"6748","company":"亞果生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-26","time":"15:17:05","subject":"本公司民國114年度合併財務報告業經提報董事會。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：亞果生醫（6748），2026-03-26 15:17，「本公司民國114年度合併財務報告業經提報董事會。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6539-2026-03-26-1509-5j9yh6","company_id":"6539","company":"麗彤","market":"興櫃","industry":"生技醫療","date":"2026-03-26","time":"15:09:38","subject":"公告本公司董事會通過114年度合併財務報告","clause":"第43款","fact_date":"2026-03-26","cite_as":"公開資訊觀測站重大訊息：麗彤（6539），2026-03-26 15:09，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6748-2026-03-26-1509-gzkpfw","company_id":"6748","company":"亞果生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-26","time":"15:09:27","subject":"本公司董事會決議不分派員工酬勞及董監事酬勞","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：亞果生醫（6748），2026-03-26 15:09，「本公司董事會決議不分派員工酬勞及董監事酬勞」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4169-2026-03-26-1508-441vkr","company_id":"4169","company":"泰宗","market":"上市","industry":"生技醫療","date":"2026-03-26","time":"15:08:55","subject":"公告本公司股票初次上市前現金增資發行新股承銷價格","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：泰宗（4169），2026-03-26 15:08，「公告本公司股票初次上市前現金增資發行新股承銷價格」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6748-2026-03-26-1504-2iz4hx","company_id":"6748","company":"亞果生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-26","time":"15:04:39","subject":"公告本公司董事會決議不發放股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：亞果生醫（6748），2026-03-26 15:04，「公告本公司董事會決議不發放股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6785-2026-03-26-1429-ts7ga2","company_id":"6785","company":"昱展新藥","market":"上櫃","industry":"生技醫療","date":"2026-03-26","time":"14:29:52","subject":"公告本公司即將收到「LONG-ACTING INJECTABLEFORMULATIONS OF KETAMINE PAMOATE SALTS」馬來西亞專利核准通知書。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：昱展新藥（6785），2026-03-26 14:29，「公告本公司即將收到「LONG-ACTING INJECTABLEFORMULATIONS OF KETAMINE PAM」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4155-2026-03-26-1336-1qkz1x4","company_id":"4155","company":"訊映","market":"上市","industry":"生技醫療","date":"2026-03-26","time":"13:36:45","subject":"代重要子公司PRODIGY DIABETES CARE, LLC.公告現金股利配發基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：訊映（4155），2026-03-26 13:36，「代重要子公司PRODIGY DIABETES CARE, LLC.公告現金股利配發基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4155-2026-03-26-1336-124ffeh","company_id":"4155","company":"訊映","market":"上市","industry":"生技醫療","date":"2026-03-26","time":"13:36:23","subject":"代重要子公司PRODIGY DIABETES CARE, LLC.公告董事會決議發放現金股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：訊映（4155），2026-03-26 13:36，「代重要子公司PRODIGY DIABETES CARE, LLC.公告董事會決議發放現金股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}